News & Updates

Abnormal p53 immunohistochemical (IHC) findings may indicate a higher risk of progression in Barrett’s oesophagus (BE) patients, a new study has found.

Metabolic dysfunction-associated fatty liver disease (MAFLD) can escalate the incidence of severe COVID-19, but no association between MAFLD and COVID-19 death has been confirmed, suggest the results of a meta-analysis.

In the treatment of patients with chronic hepatitis B (CHB), the novel tenofovir amibufenamide (TMF) is as good as tenofovir disoproxil fumarate (TDF) in terms of efficacy but with the advantage of better bone and renal safety, according to the results of a noninferiority trial.

Neurolytic splanchnic nerve block (SNB) appears effective for pain control in patients with moderate-to-severe pain due to unresectable pancreatic cancer, a study has shown.